Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016)

Neuroone Medical Technologies (NMTC) reported Liabilities from Discontinued Operations of 21807.0 for Q4 2016, up 10.02% year-over-year from 19821.0 in Q1 2016, and little changed sequentially from 21807.0 in Q3 2016.

Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016) Analysis & Trends

Neuroone Medical Technologies has disclosed Liabilities from Discontinued Operations across 2 years of filings, most recently posting 21807.0 for Q4 2016.

  • Quarterly Liabilities from Discontinued Operations rose 10.02% year-over-year to 21807.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 21807.0 (up 10.02% YoY) and the FY2016 annual result came in at 21807.0, up 10.02% from the prior year.
  • Liabilities from Discontinued Operations steadied at 21807.0 in Q4 2016, from 21807.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 21807.0 in Q2 2016 and bottomed at 19821.0 in Q4 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Neuroone Medical Technologies 26.73 Mn 23.93 Mn 990,264.00

Historic Data

Download Data
DateValue
Dec 31, 2016 21,807.00
Dec 31, 2016 21,807.00
Sep 30, 2016 21,807.00
Sep 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Dec 31, 2015 19,821.00
Dec 31, 2015 19,821.00